Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBERATE trial of glenzocimab in ST-elevation myocardial infarction
ISRCTN15443962Phase 2Terminated
- Sponsor
- University of Birmingham
- Start
- Jan 2024
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) comparing Glenzocimab with Placebo (2 arms). Primary endpoint: Myocardial infarct size. Started Jan 2024; status: terminated.
02
Drugs
glenzocimab
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ISRCTN15443962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15443962.